Efficacy and safety of the endothelinA/B receptor antagonist TAK-044 in treating subarachnoid hemorrhage. The UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.

G.J.E. Rinkel

Efficacy and safety of the endothelinA/B receptor antagonist TAK-044 in treating subarachnoid hemorrhage. The UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.

Translated title of the contribution: Efficacy and safety of the endothelinA/B receptor antagonist TAK-044 in treating subarachnoid hemorrhage. The UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.

G.J.E. Rinkel

Neurology & Neurosurgery

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Efficacy and safety of the endothelinA/B receptor antagonist TAK-044 in treating subarachnoid hemorrhage. The UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
Original language	Undefined/Unknown
Pages (from-to)	992-997
Number of pages	6
Journal	Journal of Neurosurgery
Volume	93
Publication status	Published - 2000

Cite this

@article{43e7be7b2130488ebdd558523369981f,

title = "Efficacy and safety of the endothelinA/B receptor antagonist TAK-044 in treating subarachnoid hemorrhage. The UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.",

author = "G.J.E. Rinkel",

year = "2000",

language = "Undefined/Unknown",

volume = "93",

pages = "992--997",

journal = "Journal of Neurosurgery",

issn = "0022-3085",

publisher = "American Association of Neurological Surgeons",

}